Stanley Hirsch

Stanley Hirsch has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Foamix Pharmaceuticals Ltd. and Yarrow Bioscience, Inc. In total, 17 filings cover trades dated from 13 May 2018 to 3 April 2020.

The open-market record consists of 1 sale worth €26k, with no purchase. Outside the open market, there are 9 share grants and 4 option exercises.

Most recently, on 7 April 2020, the filings show a share grant in Yarrow Bioscience, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.